Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
Go back to Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development| (NASDAQ: APVO) | Delayed: 1.83 -0.06 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $4.33 | |||
| Open | $1.88 | 52 Week Low | $1.80 | |||
| Day High | $1.90 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $0.00 | |||
| Volume | 32,968 | |||||
